Canadian-based cultivator The Green Organic Dutchman (TGOD) has completed its first commercial shipment of cannabis oils for the Australian medicinal market via a distribution agreement signed with LeafCann in 2020.
The company expects to introduce more cannabis products to the Australian and New Zealand markets in 2022.
TGOD CEO and interim CFO Sean Bovingdon said: “This shipment to Australia is an important milestone for TGOD as it marks our entry into the Asia-Pacific market. We remain laser-focused on execution as we chart the course for future growth, including opportunities in international markets.”
LeafCann CEO Elisabetta Faenza added: “LeafCann is excited to be executing on its strategy to provide high-quality products at affordable prices into the Australian market. The Green Organic Dutchman’s commitment to organic production is a real plus and a clear point of differentiation in the marketplace.”
Little Green Pharma
Little Green Pharma has reported strong revenue growth for the quarter ending September 30, 2021 with unaudited revenue of A$3.18 million and record sales of of A$1.39 million for September.
The company grew patient numbers in Australia by more than 4,580 new patients, a 39% increase on the previous quarter, and prescribers by 110, a 46% lift.
It said the growth in the domestic flower market has resulted in it redirecting some of its locally grown flower to Australia instead of Germany.
Cannim has agreed a deal to supply SunCo Green with its 20% THC sativa hybrid Jamaican cannabis flower product Medical Star to sell under its own brand via the Special Access Scheme.
The first batch is already in Australia and will be available for prescription in early November.
SunCo Green CEO Shaun Anderson said: “Cannim is unique in the global market in offering Jamaican cannabis and we are delighted to be able to offer high-quality product to our Australian patients under the SunCo Green brand.”
ASX-listed Australian agritech company Roto-Gro International is seeking a dual listing on the Canadian Securities Exchange (CSE) after inquiries from North American private equity firms.
The company, which has its operational headquarters in Canada, expects the move to present growth opportunities in North America and potentially result in a revaluation of its market position in the perishable food and legal cannabis agritech space.
In July, RotoGro received a C$213,000 non-refundable deposit from Wolf Island Cannabis for its patented and proprietary cannabis cultivation technology. Wolf Island is constructing a state-of-the-art facility in Ontario, Canada.
The June and September quarters saw MGC Pharma deliver a record US$2.2 million in cash sales receipts for a consecutive six-month period, with increasing month-on-month sales generated from new key markets including the UK and Ireland.
The quarter ending September 30 saw the firm write $964,000 in cash receipts and $564,000 of phytocannabinoid medicine sales.
ECS Botanics has entered a trading halt ahead of a proposed capital raise. The halt will remain in place until Friday (October 29), when full details should be made public.